Tag:
RespiVert
Latest Headlines
Latest Headlines
J&J's Centocor buys RespiVert
Centocor Ortho Biotech, a division of Johnson & Johnson ( NYSE: JNJ ), announced today that it has acquired acquired RespiVert, a private company that's developing small-molecule, inhaled therapies
